Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Gregory Norden

At a glance: Gregory Norden is Director at Royalty Pharma (RPRX). Their latest SEC Form 4, filed May 15, 2026, reported a sale of $161K. On file: 0 purchase lines ($0) and 1 sale line ($161K).

Disclosed holdings: about $13.0M of RPRX stock: 191,803 shares reported on their latest Form 4 (filed May 15, 2026), valued at the Nov 19, 2026 close of $67.86. This counts only RPRX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Royalty Pharma plc (RPRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $161K

Gregory Norden's InsiderPrint

2 trades from SEC Form 4 filings, 2023 to 2026, drawn as one fingerprint.

InsiderPrint of Gregory Norden: 2 trades, 2023 to 20262023: 1 buy, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 0 buys, 1 sale
  • Bump outward: a purchase (1)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
May 15SEC RPRXRoyalty Pharma plc Sell Plan 3,045191,803 held (−2%) $53.00 $161K +28.0%
  • Sell

    Director Gregory Norden sold $161K of RPRX at $53.00 — pre-scheduled 10b5-1 plan sale.

Follow Gregory Norden

Get one email when Gregory Norden files a new purchase or sale. Free.

At most one email a day about Gregory Norden, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.